by The U.S. fertility market size reached USD 5.34 billion in 2023 and is projected to hitaround USD 8.69 billion by 2033, poised to grow at a CAGR of 4.78% from 2024 to 2033.
Key Points
- By offering, the assisted reproductive technology segment dominated the market in 2023.
- By end-user, the fertility clinics segment dominated the U.S. fertility market in 2023 and the segment is observed to sustain the dominance throughout the forecast period.
The market research report on the U.S. fertility market provides a comprehensive analysis of various key aspects. It includes the definition, classification, and application of U.S. fertility products. The report examines the development trends, competitive landscape, and industrial chain structure within the industry. Furthermore, it presents an overview of the industry, analyzes national policies and planning, and offers insights into the latest market dynamics and opportunities at a global level.
Get a Sample: https://www.precedenceresearch.com/sample/3751
U.S. Fertility Market Scope
| Report Coverage | Details |
| U.S. Market Size in 2023 | USD 5.34 Billion |
| U.S. Market Size by 2033 | USD 8.69 Billion |
| Growth Rate from 2024 to 2033 | CAGR of 4.78% |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Offering and By End User |
Read More: Pharmaceutical Contract Manufacturing Market Size, Growth, Report 2033
The report presents the volume and value-based market size for the base year 2022 and forecasts the market’s growth between 2023 and 2032. It estimates market numbers based on product form and application, providing size and forecast for each application segment in both global and regional markets.
Focusing on the global U.S. fertility market, the report highlights its status, future forecasts, growth opportunities, key market players, and key market regions such as the United States, Europe, and China. The study aims to present the development of the U.S. fertility market by considering factors like Year-on-Year (Y-o-Y) growth, in addition to Compound Annual Growth Rate (CAGR). This approach enables a better understanding of market certainty and the identification of lucrative opportunities.
Regarding production, the report investigates the capacity, production, value, ex-factory price, growth rate, and market share of major manufacturers, regions, and product types. On the consumption side, the report focuses on the regional consumption of U.S. fertility products across different countries and applications.
Buyers of the report gain access to verified market figures, including global market size in terms of revenue and volume. The report provides reliable estimations and calculations for global revenue and volume by product type from 2023 to 2032. It also includes accurate figures for production capacity and production by region during the same period.
The research includes product parameters, production processes, cost structures, and data classified by region, technology, and application. Furthermore, it conducts SWOT analysis and investment feasibility studies for new projects.
This in-depth research report offers valuable insights into the U.S. fertility market. It employs an objective and fair approach to analyze industry trends, supporting customer competition analysis, development planning, and investment decision-making. The project received support and assistance from technicians and marketing personnel across various links in the industry chain.
The competitive landscape section of the report provides detailed information on xx market competitors. It includes company overviews, financials, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites, production capacities, strengths and weaknesses, product launches, product range, and application dominance. However, the data points provided only focus on the companies’ activities related to the U.S. fertility market.
Prominent players in the market are expected to face tough competition from new entrants. Key players are targeting acquisitions of startup companies to maintain their dominance. The report
Reasons to Purchase this Report:
- Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
- In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
- Market size in USD million and volume in million units provided for each segment and sub-segment.
- Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
- Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.
U.S. Fertility Market Companies
- Boston IVF Fertility Clinic
- INVO Bioscience
- San Diego Fertility Center
- Celmatix
- FUJIFILM IRVINE SCIENTIFIC
- Carolinas Fertility Institute
- Progyny Inc.
- Cook Medical
Segments Covered in the Report
By Offering
- Assisted Reproductive Technology
- IVF
- Artificial Insemination
- Surrogacy
- Others
- Fertility Drugs
- Gonadotropin
- Anti-estrogen
- Others
- Others
By End User
- Fertility Clinics
- Hospitals
- Clinical Research Institutes
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Fertility Market
5.1. COVID-19 Landscape: U.S. Fertility Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. U.S. Fertility Market, By Offering
8.1. U.S. Fertility Market Revenue and Volume, by Offering, 2024-2033
8.1.1. Assisted Reproductive Technology
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Fertility Drugs
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Others
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. U.S. Fertility Market, By End User
9.1. U.S. Fertility Market Revenue and Volume, by End User, 2024-2033
9.1.1. Fertility Clinics
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Clinical Research Institutes
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. U.S. Fertility Market, Regional Estimates and Trend Forecast
10.1. U.S.
10.1.1. Market Revenue and Volume Forecast, by Offering (2021-2033)
10.1.2. Market Revenue and Volume Forecast, by End User (2021-2033)
Chapter 11. Company Profiles
11.1. Boston IVF Fertility Clinic
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. INVO Bioscience
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. San Diego Fertility Center
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Celmatix
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. FUJIFILM IRVINE SCIENTIFIC
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Carolinas Fertility Institute
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Progyny Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Cook Medical
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
